ARES MANAGEMENT LLC purchased $2.9M of CTEV (indirect holdings)
ARES MANAGEMENT LLC purchased 115,579 indirectly-held shares of Claritev Corp (CTEV) at an average of $25.40 ($24.42–$26.14, $2.94M total) across 2 trades over 2026-11-09 to 2026-11-10. Filed jointly with ASOF II Holdings I, L.P. (10% owner), ASOF II A (DE) Holdings I, L.P. (10% owner) and ASOF III Holdings I LP (10% owner).
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of this insider purchase, offering a fresh data point for traders.
Market read
New insider buying could signal confidence and modestly lift the stock, but impact is limited by the small transaction size.
What to watch
Potential hidden liabilities or upcoming dilution events that could offset the insider's confidence.
Background
SEC Form 4 filing discloses insider transactions. ARES MANAGEMENT LLC, a 10% owner, increased its holding in Claritev Corp.
Ticker impact
Form 4 shows ARES MANAGEMENT LLC bought $2.9M of Claritev shares, increasing its stake to over 2 million shares.
likely upward pressure as the market prices in the insider buying
The $2.9M purchase is a material stake increase for a micro‑cap, but the amount is modest relative to market cap.
Market effects
Minimal; the transaction is company‑specific and does not affect the broader sector.
None; the filing is U.S.‑based and limited to Claritev.
Low; only relevant to investors tracking micro‑cap insider activity.
Counterpoint
The purchase may be a routine portfolio rebalancing rather than a strong bullish signal.
Key entities
- companyClaritev Corp
Micro‑cap biotech listed on the U.S. market under ticker CTEV.
- investorARES MANAGEMENT LLC
Investment manager and 10% owner of Claritev.
